ESTRO 2024 - Abstract Book

S2153

Clinical - Upper GI

ESTRO 2024

Conclusion:

In conclusion, our study demonstrates the potential dosimetric benefits of implementing online adaptive radiotherapy in the treatment of patients with esophageal cancer. This approach deals with interfraction variability and holds the promise of reducing radiation-related side effects. Further research and prospective studies are warranted to consolidate these findings and integrate online adaptive radiotherapy into standard practice.

Keywords: Adaptive radiotherapy, esophageal cancer

References:

1. Van Hagen P, Hulshof MCCM, Van Lanschot JJB, et al. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer. N Engl J Med. 2012 May;366(22):2074-84.

2. Shapiro J, van Lanschot JJB, Hulshof MCCM, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015 Sep;16(9):1090-98.